Skip to main content
An upper endoscopy procedure performed on some half million patients annually in the U.S. may pose risk for transmission of the emerging New Delhi variety of carbapenem-resistant Enterobacteriaceae (CRE) even if current cleaning and high level disinfection protocols are followed.

CRE endoscope outbreak raises troubling questions about reprocessing, emerging New Delhi enzyme